U.S. Paper and Forestry Products Stock News

NasdaqGS:ASML
NasdaqGS:ASMLSemiconductor

ASML Deepens Asian Chip Ties While Valuation Stretches Beyond Fair Value

ASML Holding (NasdaqGS:ASML) signed a Memorandum of Understanding with Tata Electronics to support advanced lithography solutions for India’s emerging semiconductor fab ecosystem. The agreement signals a planned role for ASML in upcoming Indian chip manufacturing projects centered around Tata Electronics. Separately, ASML is ramping up hiring in Taiwan in response to strong client demand for its lithography technology. ASML, a key supplier of advanced lithography equipment to global...
NYSE:KO
NYSE:KOBeverage

Is Coca-Cola’s Collectible Cans And New Flavors Strategy Altering The Investment Case For KO?

In recent months, Coca-Cola has reinforced its brand strength with new products like Coca-Cola Cherry Float and Coca-Cola Zero Zero, while launching a limited-edition America250 packaging campaign featuring collectible mini-cans for all 50 states, Puerto Rico, and Washington, D.C. By pairing ongoing volume growth and value share gains with scarcity-driven promotions and rewards-based engagement, Coca-Cola is using product innovation and marketing experiments to deepen consumer loyalty...
NasdaqGS:MLAB
NasdaqGS:MLABLife Sciences

Mesa Laboratories (MLAB) Profit Turnaround Tests Justification For Rich 74x P/E Multiple

Latest FY 2026 earnings snapshot Mesa Laboratories (MLAB) just closed FY 2026 with fourth quarter revenue of US$63.7 million and a loss per share of US$0.75, as net income excluding extra items came in at a loss of US$4.1 million. Over the past year the company has seen quarterly revenue move from US$62.1 million in FY 2025 Q4 to US$63.7 million in FY 2026 Q4, while quarterly EPS has swung between a loss of US$1.31 and a profit of up to US$0.87. This combination of improving trailing...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

Assessing TransMedics Group (TMDX) Valuation After A Sharp Multi Month Share Price Pullback

TransMedics Group stock: recent performance snapshot TransMedics Group (TMDX) has drawn fresh attention after a steep pullback, with the stock down about 35% over the past month and roughly 48% over the past 3 months based on recent total returns. See our latest analysis for TransMedics Group. At a share price of $70.15, TransMedics Group’s short term momentum has cooled, with the 30 day share price return declining about 35% and the 90 day share price return down around 48%, even though the...
NasdaqGS:NXPI
NasdaqGS:NXPISemiconductor

Assessing NXP Semiconductors (NXPI) Valuation After A Strong Multi Month Share Price Rally

Recent stock move sets the stage NXP Semiconductors (NXPI) has drawn fresh attention after a strong run, with the stock up about 39% over the past month and 42% over the past 3 months, prompting investors to reassess its current pricing. See our latest analysis for NXP Semiconductors. That recent surge comes on top of a strong run over the past year, with the share price showing firm upward momentum and a 1-year total shareholder return of 71%, reinforcing how quickly sentiment has shifted...
NYSE:IIPR
NYSE:IIPRIndustrial REITs

A Look At Innovative Industrial Properties (IIPR) Valuation After Senior Notes Repayment And Balance Sheet Reset

Innovative Industrial Properties (IIPR) has just cleared a key financing hurdle by fully repaying its $282 million 5.50% senior notes due May 2026 using cash, revolving credit facilities, and recent term loan proceeds. See our latest analysis for Innovative Industrial Properties. The refinancing steps around the senior notes sit alongside a steady share price recovery, with a 90 day share price return of 5.75% and a year to date share price return of 16.76%. The 1 year total shareholder...
NYSE:MOV
NYSE:MOVLuxury

Movado Group (MOV) Margin Gain And 80.4% TTM Earnings Growth Test Bullish Narratives

Movado Group (MOV) just posted Q1 2027 results with revenue of US$142.4 million and basic EPS of US$0.30, compared with trailing twelve month revenue of US$681.9 million and EPS of US$1.44 that delivered year-over-year earnings growth of 80.4%. Over the last year, revenue has been broadly steady at 0.4% growth while net profit margin moved from 2.7% to 4.7%. This sets up this quarter as part of a wider shift in the earnings profile. For investors, that margin progression, combined with the...
NYSE:ANF
NYSE:ANFSpecialty Retail

Abercrombie & Fitch (ANF) Margin Decline Tests Bullish Profitability Narratives In Q1 2027

Abercrombie & Fitch (ANF) opened Q1 2027 with revenue of US$1.1b and basic EPS of US$1.49, alongside net income of US$67.1m for the quarter. The company recorded quarterly revenue of US$1.10b in Q1 2026 and US$1.11b in Q1 2027, while basic EPS moved from US$1.63 to US$1.49 over the same period. This presents a picture in which investors are weighing solid top line scale against more mixed per share outcomes. With trailing net margin coming in lower than the prior year in the provided data,...
NYSE:JBL
NYSE:JBLElectronic

Jabil (JBL) Is Up 7.6% After Yield‑Driven Risk Rally Lifted Cyclicals Has The Bull Case Changed?

Earlier this week, Jabil was part of a broader move in U.S. equities as easing Treasury yields and progress on Iran‑US peace discussions lifted corporate confidence and demand for cyclically exposed manufacturers. This macro‑driven sentiment shift comes shortly after concerns about Jabil’s valuation and recent insider share sales, highlighting a tension between optimism and perceived risk. Next, we’ll examine how improving risk appetite tied to lower Treasury yields may influence Jabil’s...
NYSE:WFC
NYSE:WFCBanks

Is It Too Late To Consider Wells Fargo (WFC) After A 20% Year To Date Decline?

Wondering if Wells Fargo at around US$76 per share still offers value, or if most of the opportunity has already been priced in? This article breaks that question down using several valuation tools. The stock is close to its recent last close of US$76.11, with a modest 0.4% gain over the past week but a decline of 5.5% over the past month and a larger fall of 20.1% year to date, set against a 5.5% return over the last year and 106.0% over three years. Recent coverage has focused on Wells...
NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

Semtech (SMTC) Turns Q1 EPS Profit Into Test Of Ongoing Turnaround Narratives

Semtech (SMTC) opened Q1 2027 with revenue of about US$291 million, basic EPS of roughly US$0.29 and net income of around US$26.6 million, providing a clear snapshot of its latest quarterly performance. The company reported revenue of about US$251.1 million in Q1 2026 and roughly US$291 million in Q1 2027, while basic EPS moved from about US$0.22 to roughly US$0.29 over the same period. This offers investors a direct view of how the top and bottom line compare year on year. Overall, margins...
NYSE:ATEN
NYSE:ATENSoftware

A Fresh Look At A10 Networks (ATEN) Valuation After Strong Recent Share Price Performance

Stock move and recent performance context A10 Networks (ATEN) has recently attracted investor attention after its share price movement, prompting a closer look at how the stock has been trading over the past month and past 3 months. See our latest analysis for A10 Networks. A10 Networks' recent momentum has been strong, with a 30 day share price return of 5.27% and a 90 day share price return of 51.35%. The 1 year total shareholder return of 72.12% and 5 year total shareholder return of 221%...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

A Look At Walmart (WMT) Valuation After Solid Results And Cautious Outlook On Costs

Walmart (WMT) is back in focus after solid first quarter results, with revenue of US$177.8b and net income of US$5.3b, followed by cautious guidance that coincided with a sharp pullback in the stock. See our latest analysis for Walmart. That cautious first quarter outlook and worries about fuel costs have hit sentiment hard, with the share price down 9.4% over the past week and 7.1% over the past month, even though the 1 year total shareholder return is 22.9% and the 5 year total shareholder...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

A Look At Zoom Communications (ZM) Valuation After Its Corporate Rebrand And AI Platform Focus

Zoom Communications (ZM) recently completed its corporate rebrand from Zoom Video Communications, signaling a broader focus on its AI first open work platform and multi product ecosystem beyond core video meetings. See our latest analysis for Zoom Communications. At a share price of US$99.96, Zoom’s recent momentum has picked up, with a 30 day share price return of 10.05% and a 90 day gain of 32.33%. The 1 year total shareholder return of 25.47% contrasts with a 5 year total shareholder...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Assessing Berkshire Hathaway (BRK.A) Valuation After Recent Flat Performance And Mixed Momentum

Event overview and recent share performance Berkshire Hathaway (BRK.A) is back in focus after recent trading left the stock down slightly over the past week and roughly flat over the past month, prompting investors to reassess its long term role in portfolios. See our latest analysis for Berkshire Hathaway. Stepping back, Berkshire Hathaway’s share price return is down 3.4% year to date and down 4.6% over the past 90 days, while its 3 year total shareholder return of 47.3% points to stronger...
NasdaqGS:FULT
NasdaqGS:FULTBanks

Evaluating Fulton Financial (FULT) After Recent Mixed Returns And Modest Undervaluation Claims

Fulton Financial (FULT) has drawn investor attention after recent share price moves, with the stock closing at US$21.60. Short term returns have been mixed, while longer term performance remains meaningfully positive. See our latest analysis for Fulton Financial. Recent trading has been relatively muted, with the share price slipping 0.8% over the last day and 1.5% over the past month. The year to date share price return of 10.9% sits alongside a 1 year total shareholder return of 30.3%,...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Is It Too Late To Consider Qualcomm (QCOM) After Its Recent Share Price Surge?

If you are wondering whether QUALCOMM at US$233.40 still offers value or if you may be arriving late to the story, this article breaks down what the current price may imply. The stock has posted returns of 15.3% over the past 7 days, 55.3% over 30 days, 34.9% year to date, 61.8% over 1 year, 118.8% over 3 years and 93.6% over 5 years, which is likely to influence how investors think about both upside and risk. Recent coverage has focused on QUALCOMM's position in semiconductors and wireless...
NYSE:LAZ
NYSE:LAZCapital Markets

Assessing Lazard (LAZ) Valuation After Soft Q1 Results And Campbell Lutyens Acquisition

What Lazard’s board changes mean for shareholders Lazard (LAZ) is moving from a staggered, multi year board structure to annual director elections. This governance shift could change how quickly shareholders influence the company after a mixed start to the year. See our latest analysis for Lazard. The governance change comes after a mixed few months for the stock, with the share price down 9.02% over 90 days and 3.22% year to date. However, the 3 year total shareholder return is 92.91%,...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Why Recursion Pharmaceuticals (RXRX) Is Up 7.1% After Extending Cash Runway And Advancing REC-4881

Earlier in May 2026, Recursion Pharmaceuticals reported first-quarter revenue of US$6.5 million, a reduced net loss, and confirmed that its cash and cash equivalents are expected to support operations into early 2028 while advancing multiple clinical programs, including REC-4881, REC-1245, and REC-4539. A particularly interesting development is the Phase 2 efficacy signal for REC-4881 in familial adenomatous polyposis, which underscores how Recursion’s AI-native discovery platform is...
NYSE:EPD
NYSE:EPDOil and Gas

A Look At Enterprise Products Partners (EPD) Valuation After Strong Long Term Returns And Expansion Plans

Enterprise Products Partners at a glance Enterprise Products Partners (EPD) remains in focus for income oriented investors, with the stock recently closing at $37.99 and the partnership generating revenue of $51.57b and net income of $5.84b. See our latest analysis for Enterprise Products Partners. Recent trading has been a little softer, with the share price down 3.6% over the past week, but the 18.1% year to date share price return and 5 year total shareholder return of 123.9% point to...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Is Astec Industries (ASTE) Fairly Priced After Recent Infrastructure Spending Optimism?

Wondering if Astec Industries at about US$51 per share is offering fair value right now, or if the recent price puts you at risk of overpaying? The stock is up 4.9% over the last 7 days and 14.4% year to date, although it is down 13.1% over the past month, with a 31.0% return over the last year and 44.0% over three years, while the five-year return shows a decline of 20.8%. Recent headlines around infrastructure spending, construction activity and heavy equipment demand have kept attention...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet Recall Puts Omnipod Reliability And Valuation In Investor Focus

Insulet (NasdaqGS:PODD) issued a voluntary recall and medical device correction for certain Omnipod insulin Pods due to a manufacturing defect that can cause insulin under delivery. The action affects roughly 7 million Pods globally across the Omnipod 5, DASH, and Eros product lines. Insulet has received multiple reports of serious adverse events, including at least 24 severe cases requiring hospitalization, but no fatalities. The company is replacing affected Pods at no cost and does not...
NYSE:PWR
NYSE:PWRConstruction

The Bull Case For Quanta Services (PWR) Could Change Following New Buyback, Dividend And Board Appointment

Earlier this month, Quanta Services appointed Joseph Kim to its board, authorized a US$1.00 billion share repurchase program, and affirmed a quarterly dividend of US$0.11 per share payable on July 13, 2026. These moves combine fresh boardroom expertise in supply chain and logistics with capital returns that underscore management’s current priorities around buybacks and steady income. Next, we’ll examine how the new US$1.00 billion buyback authorization could influence Quanta’s existing...
NasdaqCM:CRBP
NasdaqCM:CRBPBiotechs

Corbus Pharmaceuticals (CRBP) Is Down 19.6% After FDA Aligns On CRB-701 Registrational Strategy - Has The Bull Case Changed?

Corbus Pharmaceuticals reported updated Phase 1/2 data for its Nectin-4 antibody‑drug conjugate CRB-701, showing robust activity and manageable safety in HPV‑driven oropharyngeal and cervical cancers, with plans to present the results at the ASCO 2026 meeting and to launch registrational trials in both indications. An interesting development is the FDA’s broad alignment on registrational trial designs targeting accelerated approval in second‑line oropharyngeal squamous cell carcinoma and...